Elizabeth L Hougen is EVP, Finance & CFO of IONIS PHARMACEUTICALS INC. Currently has a direct ownership of 92,905 shares of IONS, which is worth approximately $3.57 Million. The most recent transaction as insider was on Feb 02, 2024, when has been sold 2,125 shares (Common Stock) at a price of $49.54 per share, resulting in proceeds of $105,272. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 92.9K
0% 3M change
22.79% 12M change
Total Value Held $3.57 Million

ELIZABETH L HOUGEN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 02 2024
SELL
Open market or private sale
$105,272 $49.54 p/Share
2,125 Reduced 2.24%
92,905 Common Stock
Feb 01 2024
BUY
Grant, award, or other acquisition
-
4,140 Added 4.17%
95,030 Common Stock
Jan 17 2024
SELL
Open market or private sale
$437,796 $50.42 p/Share
8,683 Reduced 8.72%
90,890 Common Stock
Jan 16 2024
BUY
Exercise of conversion of derivative security
-
22,487 Added 18.42%
99,573 Common Stock
Dec 28 2023
SELL
Payment of exercise price or tax liability
$2,211,799 $50.5 p/Share
43,798 Reduced 36.23%
77,086 Common Stock
Dec 28 2023
BUY
Exercise of conversion of derivative security
$2,140,951 $47.34 p/Share
45,225 Added 27.23%
120,884 Common Stock
Feb 28 2023
BUY
Other acquisition or disposition
$4,974 $30.52 p/Share
163 Added 0.21%
75,659 Common Stock
Feb 06 2023
SELL
Open market or private sale
$84,386 $40.59 p/Share
2,079 Reduced 2.68%
75,496 Common Stock
Feb 03 2023
BUY
Grant, award, or other acquisition
-
4,140 Added 5.07%
77,575 Common Stock
Jan 18 2023
SELL
Open market or private sale
$328,716 $39.7 p/Share
8,280 Reduced 10.13%
73,435 Common Stock
Jan 17 2023
BUY
Exercise of conversion of derivative security
-
23,154 Added 22.08%
81,715 Common Stock
Aug 31 2022
BUY
Other acquisition or disposition
$5,852 $28.97 p/Share
202 Added 0.34%
58,561 Common Stock
Feb 28 2022
BUY
Other acquisition or disposition
$10,894 $28.37 p/Share
384 Added 0.65%
58,359 Common Stock
Jan 18 2022
SELL
Payment of exercise price or tax liability
$235,779 $30.12 p/Share
7,828 Reduced 11.9%
57,975 Common Stock
Jan 18 2022
BUY
Exercise of conversion of derivative security
-
22,050 Added 25.1%
65,803 Common Stock
Aug 31 2021
BUY
Other acquisition or disposition
$5,611 $33.8 p/Share
166 Added 0.38%
43,753 Common Stock
Feb 26 2021
BUY
Other acquisition or disposition
$5,167 $44.54 p/Share
116 Added 0.27%
43,587 Common Stock
Jan 15 2021
SELL
Payment of exercise price or tax liability
$378,404 $61.28 p/Share
6,175 Reduced 12.44%
43,471 Common Stock
Jan 15 2021
BUY
Exercise of conversion of derivative security
-
17,151 Added 25.68%
49,646 Common Stock
Nov 25 2020
SELL
Open market or private sale
$1,085,084 $50.05 p/Share
21,680 Reduced 40.02%
32,495 Common Stock
Nov 25 2020
BUY
Exercise of conversion of derivative security
$864,382 $39.87 p/Share
21,680 Added 28.58%
54,175 Common Stock
Nov 24 2020
SELL
Open market or private sale
$219,586 $50.83 p/Share
4,320 Reduced 11.73%
32,495 Common Stock
Nov 24 2020
BUY
Exercise of conversion of derivative security
$172,238 $39.87 p/Share
4,320 Added 10.5%
36,815 Common Stock
Nov 23 2020
SELL
Open market or private sale
$952,090 $50.11 p/Share
19,000 Reduced 36.9%
32,495 Common Stock
Nov 23 2020
BUY
Exercise of conversion of derivative security
$757,530 $39.87 p/Share
19,000 Added 33.12%
38,370 Common Stock
ELH

Elizabeth L Hougen

EVP, Finance & CFO
Carlsbad, CA

Track Institutional and Insider Activities on IONS

Follow IONIS PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IONS shares.

Notify only if

Insider Trading

Get notified when an Ionis Pharmaceuticals Inc insider buys or sells IONS shares.

Notify only if

News

Receive news related to IONIS PHARMACEUTICALS INC

Track Activities on IONS